Abstract
The series of thirty new 1-[(4-arylpiperazin-1-yl)-alkyl]-3,3-diphenyl- and 3,3-dimethyl-pyrrolidine-2,5-diones was synthesized. The anticonvulsant properties were evaluated in maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizure tests after intraperitoneal injection in mice. The motor impairment was determined in the rotorod test in parallel. Although no anti-seizure properties were found in the scPTZ screen, fourteen compounds showed protection in the MES test at a dose of 100 mg/kg which is known as animal model of human generalized tonicclonic seizures. Taking into consideration the role of 5-HT1A and 5-HT7 receptor subtypes in seizures control as well as the fact that all compounds obtained belong to the class of long-chain arylpiperazines (LCAPs), their 5-HT1A and 5-HT7 serotonin receptor affinities were determined. The most potent 5-HT1A receptor ligands are 2-OCH3 (20, 35), 3-Cl (32) and 3-CF3 (34) derivatives with Ki = 16 nM (20), 33 nM (35), 32 nM (32) and 26 nM (34). Compounds 32 and 35 reveled also high 5-HT7 receptors affinity with the the Ki values 70 nM and 47 nM, respectively. There was no correlation between anticonvulsant properties and 5-HT1A and/or 5-HT7 serotonin receptor affinity.
Keywords: Anticonvulsant activity; 5-HT1A/5-HT7 receptor ligands; Arylpiperazines; 3, 3-Disubstituted pyrrolidine-2, 5-diones; In vivo studies; In vitro studies; Succinimides.
Letters in Drug Design & Discovery
Title:Anticonvulsant Activity and 5-HT1A/5-HT7 Receptors Affinity of Piperazine Derivatives of 3,3-Diphenyl- and 3,3-Dimethyl-succinimides
Volume: 10 Issue: 2
Author(s): Jolanta Obniska, Iwona Chlebek, Krzysztof Kaminski, Andrzej J. Bojarski and Grzegorz Satala
Affiliation:
Keywords: Anticonvulsant activity; 5-HT1A/5-HT7 receptor ligands; Arylpiperazines; 3, 3-Disubstituted pyrrolidine-2, 5-diones; In vivo studies; In vitro studies; Succinimides.
Abstract: The series of thirty new 1-[(4-arylpiperazin-1-yl)-alkyl]-3,3-diphenyl- and 3,3-dimethyl-pyrrolidine-2,5-diones was synthesized. The anticonvulsant properties were evaluated in maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizure tests after intraperitoneal injection in mice. The motor impairment was determined in the rotorod test in parallel. Although no anti-seizure properties were found in the scPTZ screen, fourteen compounds showed protection in the MES test at a dose of 100 mg/kg which is known as animal model of human generalized tonicclonic seizures. Taking into consideration the role of 5-HT1A and 5-HT7 receptor subtypes in seizures control as well as the fact that all compounds obtained belong to the class of long-chain arylpiperazines (LCAPs), their 5-HT1A and 5-HT7 serotonin receptor affinities were determined. The most potent 5-HT1A receptor ligands are 2-OCH3 (20, 35), 3-Cl (32) and 3-CF3 (34) derivatives with Ki = 16 nM (20), 33 nM (35), 32 nM (32) and 26 nM (34). Compounds 32 and 35 reveled also high 5-HT7 receptors affinity with the the Ki values 70 nM and 47 nM, respectively. There was no correlation between anticonvulsant properties and 5-HT1A and/or 5-HT7 serotonin receptor affinity.
Export Options
About this article
Cite this article as:
Obniska Jolanta, Chlebek Iwona, Kaminski Krzysztof, J. Bojarski Andrzej and Satala Grzegorz, Anticonvulsant Activity and 5-HT1A/5-HT7 Receptors Affinity of Piperazine Derivatives of 3,3-Diphenyl- and 3,3-Dimethyl-succinimides, Letters in Drug Design & Discovery 2013; 10 (2) . https://dx.doi.org/10.2174/157018013804725116
DOI https://dx.doi.org/10.2174/157018013804725116 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Investigation and Need of Bioequivalence Study: Methodology and Regulatory Requirement
Applied Clinical Research, Clinical Trials and Regulatory Affairs Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
Current Medicinal Chemistry Therapeutic Role of Zonisamide in Neuropsychiatric Disorders
Mini-Reviews in Medicinal Chemistry In-vitro Functionality of Clozapine Biphasic Release Minitablet Using Advanced Statistical Tools
Drug Delivery Letters Impact of Dietary Fats on Brain Functions
Current Neuropharmacology Clinical Profile of Mortality among Chronic Schizophrenic Patients: A Local Pilot Survey in Iran
Current Psychiatry Research and Reviews Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry The New Antiepileptic Drugs Pharmacological and Clinical Aspects
Current Pharmaceutical Design Bispidine as a Privileged Scaffold
Current Topics in Medicinal Chemistry Medial Temporal Lobe Volumes in Amnestic Mild Cognitive Impairment and Late-life Depression: Research Synthesis
Current Psychiatry Reviews Molecular Biomarkers for Amyotrophic Lateral Sclerosis
Current Bioinformatics Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases
Current Pharmaceutical Design Cognitive Impairment and Mossy Fiber Sprouting in a Rat Model of Drug-resistant Epilepsy Induced by Lithium-pilocarpine
Current Neurovascular Research Extract of <i>Moringa concanensis</i> Nimmo Leaves Ameliorates Hyperglycemia and Oxidative Stress, and Improves β-cell Function in Alloxan Monohydrate Induced Diabetic Rats
Current Bioactive Compounds Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission
Current Pharmaceutical Design Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms
CNS & Neurological Disorders - Drug Targets Heat Shock Proteins and Ion Channels. Functional Interactions and Therapeutic Consequences
Current Pharmaceutical Biotechnology Perspective on mTOR-dependent Protection in Status Epilepticus
Current Neuropharmacology PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives
Current Radiopharmaceuticals Discovery of New Inhibitors of Urease Enzyme: A Study Using STD-NMR Spectroscopy
Letters in Drug Design & Discovery